Phase II Study of Neoadjuvant Chemotherapy With Doxorubicin Followed by Docetaxel-Cisplatin in Locally Advanced Breast Cancer

Not Applicable

Completed

• Conditions: Breast Cancer
• Interventions: Drug: Doxorubicin, Docetaxel, Cisplatin

• Registration Number: NCT00538525
• Lead Sponsor: King Faisal Specialist Hospital & Research Center

Brief Summary

Phase II study of neoadjuvant chemotherapy with Doxorubicin followed by Docetaxel-Cisplatin in locally advanced breast cancer

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09
• Study First Submitted: 2007-10-01
• Study First Submitted QC: 2007-10-01
• Study First Posted: 2007-10-02
• Primary Completion: 2008-04
• Study Completion: 2008-04
• Status Verified: 2012-05
• Last Update Submitted: 2012-05-26
• Last Update Posted: 2012-05-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Patients with locally advanced breast cancer

Exclusion Criteria

• Patients with metastatic breast cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Arm 1	Doxorubicin, Docetaxel, Cisplatin	Doxorubicin, Docetaxel, Cisplatin

Primary Outcome Measures

Name	Time	Method
Effectiveness	overall